HUM — Humana Cashflow Statement
0.000.00%
HealthcareBalancedLarge CapNeutral
- $62.84bn
- $69.26bn
- $92.87bn
- 70
- 43
- 87
- 75
Annual cashflow statement for Humana, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,683 | 2,707 | 3,367 | 2,934 | 2,802 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 948 | 149 | 107 | -1,014 | 231 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,186 | 1,691 | 1,354 | -386 | 809 |
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Gains / Losses on Investment Securities | |||||
Change in Reinsurance Receivable | |||||
Cash from Operating Activities | 2,173 | 5,284 | 5,639 | 2,262 | 4,587 |
Capital Expenditures | -612 | -736 | -964 | -1,316 | -1,120 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -2,475 | -542 | -2,101 | -5,240 | 114 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3,087 | -1,278 | -3,065 | -6,556 | -1,006 |
Financing Cash Flow Items | -640 | -623 | -939 | -337 | 1,987 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -785 | -2,295 | -1,955 | 3,015 | -1,914 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,699 | 1,711 | 619 | -1,279 | 1,667 |